Judge orders broader access to Plan B; Orexo lead drug fails IIa study for rhinitis;

> The FDA was wearing Republican-colored glasses when it barred teenage girls from the morning-after contraceptive Plan B, a federal judge ruled yesterday. U.S. District Judge Edward Korman lambasted the agency for putting politics above public health and ordered FDA to let 17-year-olds have access to the drug, known as Plan B. FiercePharma

> Sweden's Orexo says that a mid-stage trial of an experimental therapy for allergic rhinitis failed to demonstrate efficacy in reducing symptoms when compared to a placebo. But the developer still believes that the drug could work against COPD. FierceBiotech

> In a recent letter to Congress, a group of health policy experts urged the creation of a network to share information on Medicare and Medicaid patients to improve treatment received. In particular, Lynn Etheredge wants information to be shared on "dual eligibles"--low income, elderly patients who receive money for care from both Medicare and Medicaid. FierceHealthIT

> Hospital Impact's Tony Chen invites everyone to follow his blog on Twitter. Hospital Impact

And Finally... I can tell you right now, this is not the way to reconcile with anyone...at least I don't think it is. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.